Month: April 2020

AUSTIN, Texas, April 13, 2020 (GLOBE NEWSWIRE) — Ideal Power Inc. (NASDAQ: IPWR), pioneering the development and commercialization of highly efficient and broadly patented B-TRAN™ bi-directional power switches, will host a business update conference call on Tuesday, April 14, 2020 at 4:30 p.m. Eastern time. A press release detailing key updates will be issued prior to the call.Ideal Power Chairman, CEO and President Dr. Lon Bell, CFO Tim Burns and B-TRAN Chief Commercial Officer Dan Brdar will host the conference call, followed by a question and answer period.To access the call, please use the following information:Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact MZ...

ESCONDIDO, Calif., April 13, 2020 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (Nasdaq: OSS), a leader in specialized high-performance edge computing, has initiated a structural change and expense reduction designed to align the company’s operations and goals with current market uncertainty while positioning OSS for future growth.   The company expects the program to be substantially complete in the current quarter and realize savings of $2.5 million to $3 million on an annual basis.This initiative involves immediate selective workforce and expense reductions companywide, including at the senior management level. Other key changes include consolidating acquired operations and realignment of managerial responsibilities.   Earlier this year, the company’s board of directors implemented a change in senior leadership to deploy a different...

HOUSTON, April 13, 2020 (GLOBE NEWSWIRE) — C-Bond Systems, Inc. (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, today announced the formation of a Medical Advisory Board to advance the breadth and use of products offered by C-Bond Safety Solutions Group, primarily its C-Bond FN Nano® Coating, which is used in hospitals and other facilities to reduce the spread of pathogens including COVID-19.The founding members of the Medical Advisory Board include Sergio Moreira, Jr., M.D., and Anil Vaidya, M.D., both recognized global experts in their respective fields.Dr. Moreira is a Diplomate of the American Board of Urology and a member of the Brazilian Medical Association and Brazilian Urologic Society. He is also a Lieutenant Colonel in the U.S. Army Reserves.  He has received numerous awards and scholarships...

Company Working with Suzhou GH New Energy Technology Co. Ltd., a division of GCL Poly, to Perform Essential Modifications to Solar Cells in the Manufacture of Hydrogen Production PanelsSANTA BARBARA, CA, April 13, 2020 (GLOBE NEWSWIRE) —  HyperSolar, Inc. (OTC:HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, today announced that it is working with Suzhou GH New Energy Co. Ltd., a division of GCL Poly, to make the final modifications to the solar cells required to manufacture the Gen 1 hydrogen production panels to be used in demonstration pilot plants.   “While we have experienced some delays in processing due to Covad 19, the work in China is now ongoing,” said Tim Young, CEO of HyperSolar.  “We have evaluated many suppliers globally and have found that our connection to Suzhou...

Nes Ziona, Israel, April 13, 2020 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the Israel Innovation Authority (IIA) selected the Company’s planned COVID-19 and sepsis clinical programs to receive, in the aggregate, a non-dilutive grant of approximately $1.5 million for the period through the first quarter of 2021.  To date, Enlivex has received a total of approximately $4.31 million in grants from the IIA for its historical clinical trials and development.The IIA is an independent, publicly funded agency charged with fostering the development of industrial R&D within the State of Israel. It provides non-dilutive grants that become repayable only through royalties from future sales of products developed with the support of the IIA, and the repayment,...

VANCOUVER, Colombie-Britannique, 13 avr. 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (« Champignon » ou la « société ») (CSE : SHRM) (FWB : 496) (OTC : SHRMF), une société des sciences de l’optimisation humaine concentrée sur l’application de protocoles de traitement nouveaux et naturels pour traiter un large éventail de troubles et de carences en mettant l’accent sur la médecine psychédélique, continue de progresser dans le domaine de la médecine psychédélique grâce à l’acquisition d’un important exploitant de clinique de kétamine au Canada, d’un agrégateur de PI en médecine psychédélique et d’un développeur de nouveaux médicaments (la « transaction »). Dans cette mesure, la société est heureuse d’annoncer qu’elle a conclu un accord définitif (l’« accord ») pour acquérir 100 % d’AltMed Capital Corp. (« AltMed »).LE PERSONNELLe...

FRAMINGHAM, Mass., April 13, 2020 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced receipt of the CE (Conformité Européenne) mark for its first-in-class would care product, AC5TM Topical Hemostat (“AC5”).The CE mark provides authorization to commercialize AC5 in Europe as a dressing and to control bleeding in skin wounds in both out- and in-patient settings.Chief Executive Officer, Terrence W. Norchi, MD, said, “Experts continue to describe their desire for a hemostatic wound dressing with the broad array of features and benefits that AC5 offers. We expect earliest adoption to be in complicated acute surgical wounds as well as wounds that require better sharp debridement and...

MOORESTOWN, N.J., April 13, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare Corporation® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced today a partnership with Irvine-based HealthQuest Esoterics, Inc. to support the preparation and delivery of thousands of testing kits for the detection of SARS-CoV-2, the virus that causes Coronavirus Disease 2019 (COVID-19). The testing kits will be available for TRHC’s PrescribeWellness nationwide network of community pharmacies.TRHC’s COVID-19 operationalized response preceded the U.S. Department of Health & Human Services (HHS) recent declaration granting licensed pharmacists authority under the Public Readiness and Emergency Preparedness Act (PREP Act). This landmark announcement, a testament to the critical role of the pharmacist in...

TUSTIN, Calif., April 13, 2020 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the appointment of two senior directors of business development with responsibility for driving CDMO business growth within North America, Europe and Asia.  Jason C. Brady, Ph.D. will serve as senior director of business development for the eastern region of North America, as well as Europe.  Sylvia Hinds has been named senior director of business development for the western region of North America in addition to the Asia Pacific region.Dr. Brady is an accomplished sales professional with an...

VANCOUVER, British Columbia, April 13, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTC: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, continues to accelerate its advancements within the psychedelic medicine arena via the acquisition of a leading Canadian ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer (the “Transaction”). To this extent, the Company is pleased to announce that it has entered into a definitive agreement (the “Agreement”) to acquire 100% of AltMed Capital Corp. (“AltMed”).PERSONNELAltMed’s chief executive officer, Dr. Roger McIntyre, is a professor of psychiatry and...